Hard to have much of an opinion. S100 has shown results in murine models but then again, what hasn't?
Qure do not seem to show which AAV serotype they're using, and no indication of mode of delivery of the virus. A cursory check says they're looking to enter the clinic in 2016. Safe to say that there are still some steps left to take.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.